[{"Assets_0_FY_USD":863560000.0,"CommonStockSharesOutstanding_0_FY_shares":52797516.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-365997000.0,"NetIncomeLoss_4_FY_USD":-368009000.0,"NetIncomeLoss_1_FY_USD":-99261000.0,"StockholdersEquity_0_FY_USD":146469000.0,"Ticker":"CLVS","CIK":"1466301","name":"CLOVIS ONCOLOGY, INC.","OfficialName":"Clovis Oncology Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"317205570.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190228"}]